COMP <GO>
MMED vs MMSI // ENTERPRISE SCALE & MARKET CAP
MiniMed Group Inc. (NASDAQ) VS. Merit Medical Systems Inc. (NASDAQ) • 15-METRIC TALLY: MMED 6
— MMSI 6
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MMSI
LAST: $18.90 (+3.39%) • MKT CAP: $5.14B
market-cap
$5.14B
LAST: $84.31 (-2.24%) • MKT CAP: $5.17B
market-cap
$5.17B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMED VS. MMSI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMED | MMSI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.20% | 48.70% | +5.50 | MMED | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.90% | 7.80% | -11.70 | MMSI | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 23.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.75% | 3.87% | -11.62 | MMSI | /fcf-yield <GO> |
| Operating Margin | -6.10% | 12.20% | -18.30 | MMSI | /operating-margins <GO> |
| Net Profit Margin | -10.70% | 8.50% | -19.20 | MMSI | /net-margins <GO> |
| Revenue Growth (YoY) | 14.30% | 11.80% | +2.50 | MMED | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.82 | 4.62 | +0.20 | MMED | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | MMSI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.5 | 43.5 | +1.00 | MMED | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.94 | +0.11 | MMED | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.0x | 40.4x | -16.40 | MMED | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.14B | $5.17B | -$24.0M | MMSI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMED REV | MMSI REV | MMED GROSS % | MMSI GROSS % | MMED FCF | MMSI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.10B | $1.52B | 54.2% | 48.7% | -$420.0M | $215.7M |
| FY 2024 | $2.71B | $1.36B | 56.3% | 47.4% | -$53.0M | $185.7M |
| FY 2023 | $2.47B | $1.26B | — | — | -$70.1M | $88.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMED // BETA 1.05
MMSI // BETA 0.94